Advertisement

Topics

uniQure N.V.: uniQure Announces Second Quarter 2017 Financial Results and Recent Company Progress

07:04 EDT 8 Aug 2017 | FinanzNachrichten

~ Advancing Gene Therapy Programs in Hemophilia B and Huntington's Disease ~ ~ Provides Update on Research Collaboration with Bristol-Myers Squibb ~ ~ Makes New Appointments to Company Leadership a...

Original Article: uniQure N.V.: uniQure Announces Second Quarter 2017 Financial Results and Recent Company Progress

NEXT ARTICLE

More From BioPortfolio on "uniQure N.V.: uniQure Announces Second Quarter 2017 Financial Results and Recent Company Progress"

Quick Search
Advertisement
 

Relevant Topics

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Huntington's Disease
Huntington's disease is a hereditary disease caused by a defect in a single gene on Chromosome 4 that is inherited in an autosomal dominant fashion. The defect causes a part of DNA, called a CAG repeat, to occur many more times than it is supposed to...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...